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a  b  s  t  r  a  c  t
Background:  SARS-CoV-2  has  spread  globally.  Currently,  literature  of  SARS-CoV-2  in  neonates  is  scarce.
We  present  a case  of a neonate  with  a  high  viral  load  and  prolonged  virus  shedding.
Methods:  Epidemiology,  clinical  characteristics,  treatment,  laboratory  data  and  follow-up  information
and  the  treatment  of  a neonate  with  COVID-19  were  recorded.
Results:  A 7-day-old  boy  was  admitted  to  the  hospital  with  fever,  lethargy  and  apnoea.  He  was  found
SARS-CoV-2  RNA  positive  with  an exceptionally  high  viral  load  in nasopharyngeal  swab  and  stool.  The
father  and  two  maternity  nurses  at home  had detectable  SARS-CoV-2  RNA  as  well.  Sequencing  showed  all
strains belonged  to the  same  cluster.  The  father  was  asymptomatic  and  the maternity  nurses  developed
symptoms  after  visiting.  In  the  mother,  no SARS-CoV-2  RNA could  be  found.  Six days  after  admis-
sion,  the  neonate  was  discharged  after  clinical  improvement  with  oral  antibiotics  because  of  a  possible
pyelonephritis.  Monitoring  the  course  of  this  infection  showed  that  SARS-CoV-2  RNA  was  detectable  in
the  nasopharynx  until day  19 and  in stool  until  day  42  after  symptom  onset.
Conclusions:  This  case  shows  that neonates  can  have  a high  viral  load  of  SARS-CoV-2  and  can  shed  the
virus  for  over  one  month  in stool.  Despite  the  high  viral  load  in  the  neonate,  the  mother  and  a  sibling did
not  get  infected.
©  2020  The  Authors.  Published  by Elsevier  Ltd on behalf  of King  Saud  Bin  Abdulaziz  University  for










Starting from December 2019, a novel coronavirus (SARS-CoV-
2), causing coronavirus disease 2019 (COVID-19), has spread on
a global scale [1]. Compared to adults, children seem to be less
affected by SARS-CoV-2 infection as they are usually asymptomatic
or have mild symptoms [1–4]. However, little is known about dis-
ease severity in neonates, the need for treatment and their role
in transmission of SARS-CoV-2 [5]. It is reported that children or
neonates can have high viral loads, while remaining asymptomatic
or having mild symptoms [6,7]. However, there is no clear associa-
tion between the viral load and infectivity.
Furthermore, in children aged between 2 months and 15 years,
SARS-CoV-2 RNA could still be detected in their stool in up to 70
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ays [4,8,9]. Data about duration of viral shedding in neonates is
carce [10,24,27,33].
In this case report we  present a 7-day-old neonate who was
ospitalized in the Netherlands with COVID-19 and had a high viral
oad of SARS-CoV-2 in the nasopharynx and stool. We  reviewed the
iterature and investigated the duration of viral shedding and the
ource of infection. Only detection of viral RNA was described in
his article, not the isolation of live virus.
ase presentation
A 7-day old boy was admitted to the emergency ward of the
mphia hospital in Breda, the Netherlands because of fever (rec-
al temperature 38.4–39.4 ◦C), lethargy and apnoea. The day before
his presentation, he was  treated with phototherapy for 1 day for
yperbilirubinemia. He had no runny nose and no tachypnoea, oxy-
en saturation was  99% on room air, and auscultation of his lungs
as clear. All laboratory characteristics are presented in Table 1.
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Table  1
Laboratory characteristics.
Days since positive PCR SARS-CoV-2 neonate Day-1 Day 0-morning Day 0-evening Day 1 Day 2 Day 5
Haemoglobin, g/L 11.8 10.6 11.1 10.3
White blood cell count, × 109/L 7.3 8.6 15.1 7.4
Lymphocyte count, × 109/L 1.47 3.84
Platelet count, × 109/L 258 269 254 158
C-response protein, mg/L 1 1 5 54 23
Alanine aminotransferase, U/L 14
Aspartate aminotransferase, U/L 51
Total bilirubin, mmol/L 362 229 203 201
Creatine kinase, U/L 101
Lactate dehydrogenase, U/L 634 499
Urine - White blood cell count, × 109/L >800 22
Urine  - erythrocyt count, × 109/L <5 <5
Lumbar puncture - white blood cell count, × 109/L 1
Lumbar puncture - erythrocyt count, × 109/L 1000
Blood  culture Neg
Urine  culture Neg
PCR  Enterovirus/ parechovirus (stool) Neg




































PCR influenza/RSV (nasopharyngeal swab) 
(Abbreviations: COVID-19 = new coronavirus 2019, PCR = polymerase chain reactio
Only the first lymphocyte count was low and there was an increase
of c-response protein on day 1. Since there were no respiratory
symptoms, no chest radiograph was performed. Because of his
age, a total sepsis work-up was performed including complete
blood count, urinalysis, cerebrospinal fluid (CSF) studies, blood,
urine and CSF culture, and nasopharyngeal swab and stool for PCR
viruses. After the work-up, empirical therapy for late-onset sepsis
(intravenous therapy of amoxicillin and cefotaxime) was initiated.
SARS-CoV-2 RNA was detected in a nasopharyngeal swab and stool
by a semi-quantitative real-time reverse transcriptase polymerase
chain reaction (sqRT-PCR) with low cycle threshold (Ct)-values of
13.9 and 20.5 respectively, suggesting a high viral load [11,12]. No
SARS-CoV-2 RNA was found in urine and CSF. sqRT-PCR was neg-
ative for other pathogens on nasopharyngeal swab, CSF and stool
(Table 1). Blood and urine bacterial culture remained negative. The
urine culture could be false negative because of the antibiotics
which were administrated prior to the urine sample. Because of that
fact and leukocyturia, a possible bacterial pyelonephritis could not
be excluded. From three days post-symptom onset, there were no
clinical symptoms with stable parameters. Six days after admission,
the neonate was discharged in good condition with oral antibiotics
(amoxicillin 80 mg/kg) for three more days.
Course of infection
No COVID-19-related symptoms were recorded during the 14
days follow-up after discharge. Nasopharyngeal swab remained
SARS-CoV-2 RNA positive until day 19 and became negative after
day 20 of disease onset. Stool samples remained positive until day
42 (Fig. 1).
Source of infection
The neonate had been delivered vaginally at term after an
uneventful pregnancy and was breastfed. We  investigated the
source of this infection and Fig. 1 illustrates the dates of expo-
sure, illness onset and sampling and real-time RT–PCR results of
nasopharyngeal and rectal swabs of close-contacts of the boy. His
parents did not report fever or upper airway complaints. His two-
year-old sister had a runny nose for weeks and his grandparents
reported a fever with upper airway complaints (runny nose and
cough) 28 days before unset of illness of the boy. Maternity nurse 1
(MN1) to.ok care for the neonate for one day at home without symp-





 = respiratoir syncytieel virus, pos = positive, and neg = negative).
ever for the first time. One day after the visit, she developed a sore
hroat. Maternity nurse 2 (MN2) started working without symp-
oms the day after the visit of MN1. She had symptoms of fever,
eadache and chest pain one day after visit as well. The father, MN1,
nd MN2  tested SARS-CoV-2 RNA positive, with initial nasopharyn-
eal Ctvalues 33.3, 18.3 and 26.2 respectively (Fig. 1). Follow-up
howed that the father had an increasing viral load on day 6 (Ct-
alue 21.9). Both mother and sister remained SARS-CoV-2
RNA negative at day 13 and day 19, respectively. Expressed
reast milk was tested negative.
Whole genome sequencing of the virus from the nasopharyngeal
wab specimens was performed as described before [13]. MN2  and
he neonate had identical genomes while the father and MN1  had
 difference of 1 single-nucleotide polymorphism, placing all viral
enomes in one cluster. A phylogenetic tree was constructed con-
aining all Dutch SARS-CoV-2 sequences using IQ-TREE under the
TR+F+I+G4 as best predicted model using the ultrafast bootstrap
ption [14,15].
To investigate whether mother and sister had previously been
nfected and already turned negative SARS-CoV-2 PCR results,
erum samples were tested at day 3 and day 19 (mother) and day 19
sister) for the presence of IgG antibodies against SARS-CoV-2 using
n enzyme linked immunosorbent assay (ELISA) kit (EUROIMMUN,
uebeck, Germany); both tested negative.
eview of the literature
An electronic search was  conducted on studies published from 1
ecember 2019 to 29 June by searching for the keywords ‘covid-19’
R ‘covid’ OR ‘SARS-CoV-2’ AND ‘neonate’ on PubMed, MEDLINE,
oogle Scholar, medRxiv, and bioRxiv database. We  also searched
he references listed within the articles to identify additional
rticles that may  have been missed during the electronic search. Eli-
ible studies (including case reports, case series, cohort studies and
etrospective studies) published in English-language journals that
ave described neonates diagnosed with COVID-19 were included
or analysis. We  summarized the studies involving neonates in
ables 2A and 2B [10,16–34]. Most of these neonates had an infected
other and were asymptomatic (n = 7) or became symptomatic
fter 16 h until 17 days after birth (n = 20).
They all recovered. To our knowledge, there is only one
eries report about neonates that showed viral loads (Ct val-
es) in neonates. This report included 18 neonates and infants




















Summary of studies of neonates with confirmed COVID-19.
Author Han et al
[10]. (n = 1)
Aghdam et al
[16]. (n = 1)
Wang et al.
[17]. (n = 1)
Zeng et al
[18]. (n = 3)
Zhang et al
[19]. (n = 4)
Coronado
Munoz et al
[20]. (n = 1)
Dumpa et al
[21]. (n = 1)
Salik et al
[22]. (n = 1)
Precit et al
[23]. (n = 1)
Piersigilli et al
[24]. (n = 1)
Paret et al
[25]. (n = 1)
Alzamora et al




38 Unknown 40 39, 39 >39 36 39 37 39 26 + 4 Unknown 33




27 days 15 days 36 h Unknown 30 h–17 days 21 days 22 days 7 days 10 days 7 days 25 days 16 h
Mode  of
delivery












































































PCR  NP, stool,
plasma, and
urine
PCR NP PCR NP / PCR NP and
anal swabs














Horizontal Horizontal Vertical? Horizontal Horizontal Horizontal Horizontal Horizontal Horizontal Vertical? Horizontal Vertical?
Outcome Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered
(Abbreviations: ASAT = Aspartate aminotransferase, CK = Creatine kinase, COVID-19 = coronavirus disease 2019, CRP = C-reactive protein, CS = sectio caesarea, GA = gestational age, MCH  = mean cell hemoglobin, MCV  = mean cell




















Summary of studies of neonates with confirmed COVID-19.
Author Diaz et al
[27]. (n = 1)
Gregorio-
Hernandez
et al [28]. (n =
2)
White et al
[29]. (n = 2)
Hu et al [30].
(n = 1)
Buonsenso
et al [31]. (n =
1)




[33]. (n = 1)





38 + 4 38 + 1, 39 39, 39 40 38 + 3 39 Unknown 32




8 days 2 days, 6 days 16 days, 25
days
36 h 15 days 14 days 26 days 4 days
Mode  of
delivery






















































PCR  NP PCR NP PCR NP PCR NP PCR NP PCR NP PCR NP, stool PCR NP







Horizontal Horizontal Horizontal Horizontal Horizontal Horizontal Horizontal Vertical?
Outcome Recovered Recovered Recovered Recovered Recovered Recovered Recovered Recovered
(Abbreviations: ASAT = Aspartate aminotransferase, CK = Creatine kinase, COVID-19 = coronavirus disease 2019, CRP = C-reactive protein, CS = sectio caesarea, GA = gestational age, MCH  = mean cell hemoglobin, MCV  = mean cell
volume,  NP = nasopharyngeal swab, PCR = polymerase chain reaction, PCT = procalcitonine).
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Fig. 1. Chronology of major epidemiological events and molecular testing results o
Adm  = admission, BM = breast milk, CSF = cerebrospinal fluid, CT = cycle threshold va
chain  reaction, ReAdm = readmission, SNP = single Nucleotide Polymorphisms, WG
between 3.00–6.58 [7]. Addiotionally, there are some case reports
that report viral shedding in neonates. Gordon et al. reported the
longest shedding of 28 days (nasopharyngeal swab) in a neonate
[34]. Han et al. reported virus shedding in nasopharyngeal swab
until day 17, stool until day 18, and urine until day 10 after onset
of symptoms of a 27-day old neonate [10].
Discussion
We  report a 7-day-old neonate with COVID-19 confirmed by
PCR and with possible pyelonephritis. He had no respiratory or
gastrointestinal symptoms. A high viral load of SARSCoV-2 RNA
was found in nasopharynx and stool specimens and remained pos-
itive until day 42. The father, who had no clinical symptoms, and
two maternity nurses who cared for the boy for one day only,
were both positive for SARS-CoV-2 RNA and (one of them) prob-
ably infected this neonate. The mother had not previously been
infected and was not infected by this neonate during the period
of viral shedding despite the high viral load. As described in cur-
rent literature, symptoms of COVID-19 in newborns were mild, or
even none with complete recovery; which is consistent in our case
report [7,10,16–34]. In most cases, the mother was infected and
probably transmitted horizontally to the neonate. The mother in
our case repeatedly tested negative for SARS-CoV-2 by PCR, and
no IgG sero-reactivity was seen. Therefore, we conclude that the
mother was not the source of this infection [35].
Literature shows SARS-CoV-2 incubation period are between
4–21 days [1–3,11]. This neonate became symptomatic 1.5 and 2.5
days after the visit of the maternity nurses. In this case, it is hard
to determine the source of the infection. The neonate was born in
the hospital and stayed for 1 day after birth, the father showed no
symptoms and the maternity nurses showed symptoms 1 day after
visiting this family. Sequencing showed all strains belonged to the
same cluster. A relative fast incubation time could be possibly due
to the high viral load of SARSCoV-2 RNA in our neonate. These Ct
values are lower compared to children and adults [35–37]. Possible
explanation include that neonates are presenting earlier in illness
course than older people.
Viral shedding in different specimen types such as stool, urine,
CSF, or blood remains uncertain in neonates. Limited data have
shown that viral RNA could be detected in plasma or serum of
neonates [10,22,25] and adult patients [37]. Just one case report
detected viral RNA in urine of a neonate [10]. A recent review
A
M
188nate and close-contacts after positive PCR SARS-CoV-2 in neonate (Abbreviations:
N = maternity nurse, neg = negative, NP = nasopharyngeal swab, PCR = polymerase
ole-genome sequencing).
oncluded that 3.7% of 430 adult patients were positive in urine
38]. We  tested for SARS-CoV-2 RNA in urine, nasopharyngeal
wab, stool, and CSF of the neonate, only nasopharyngeal swab
nd stool sample tested positive with prolonged virus shedding
Tables 2A and 2B). This is consistent with the current literature
f children, PCR in stool was positive until 70 days in children
8,9,11,39,40,41]. The duration of viral shedding in neonates is
carce. Because of prolonged shedding in stool, it is necessary to be
ware of the possibility of fecal-oral transmission of SARS-CoV-2
nfection, especially in neonates and children.
Additionally, due to the relatively long duration of viral shed-
ing, caution should be taken with diagnosis of COVID-19 in
eonates and children presenting with COVID-19 like symptoms.
Currently, there is no consensus on infectivity during viral shed-
ing [42,43]. Culture of live virus was  not possible in our hospital.
olfel et al. demonstrated that live virus SARS-CoV-2 can be cul-
ured from nasal/throat and sputum samples in patients, however,
o live virus was successfully isolated after day 8 from symptom
nset despite ongoing high viral loads [43]. Bullard et al. inves-
igated 90 SARS-CoV-2 RT-PCR confirmed positive samples and
etermined their ability to infect Vero cell lines. In this study, 28.9%
emonstrated viral growth and they concluded that infectivity of
atients with Ct >24 and duration of symptoms >8 days may  be
ow [12]. Further research is needed to determine the viability of
he virus outside and the duration of infectivity.
onclusion
In conclusion, data of neonates with COVID-19 are very limited.
his case report showed a neonate with a high viral load of SARS-
oV-2 and prolonged shedding with complete recovery. Thereby,
nly nasopharyngeal secretion and stool swab tested positive. Stool
emained positive the longest until day 42. However, this course of
nfection is limited by this single case, additional data on COVID-
9 infected neonates are necessary to confirm these findings. Until
hen, isolation of children or neonates with COVID-19 symptoms
hould be performed as soon as possible to prevent transmission
o health care professionals and others.uthors’ contributions
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Appendix A. Supplementary data
Supplementary material related to this article can be found,
in the online version, at doi:https://doi.org/10.1016/j.jiph.2020.10.
013.
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